US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Quasi-New Stocks

670.15

+28.864.50%

Number of Gainers:132

Number of Losers:48

Number of Flat:8

PE:- -

High:677.26

Open:650.43

Low:650.43

Close:641.21

Loading ...

Paul R. Vigano, 10% Owner, Reports Disposal of Common Shares in Aveanna Healthcare Holdings Inc

J.H. Whitney Equity Partners VII, LLC Reports Disposal of Common Shares of Aveanna Healthcare Holdings Inc

Regencell Bioscience Holdings Ltd trading halted, volatility trading pause

EverCommerce Is Maintained at Equal-Weight by Barclays

Gold Futures Slump as U.S., China Agree to Substantial Tariff Cuts -- Commodities Roundup

Regencell Bioscience Shares Soar 24.6%

THOMSON REUTERS

What to expect in the week ahead for the altcoin market: KAITO, STX and more 7 seconds ago

Eric Trump-backed American Bitcoin to go public through all-stock merger

US Stock Crypto Concept Stocks Soar, Coinbase Up 4.21%

Analysts’ Top Healthcare Picks: Tenaya Therapeutics (TNYA), Green Thumb Industries (GTBIF)

NeuroPace (NPCE) Gets a Buy from Lake Street

Top Premarket Decliners

MT Newswires Live

Analysts’ Opinions Are Mixed on These Healthcare Stocks: InflaRx (IFRX), Treace Medical Concepts (TMCI) and Amarin (AMRN)

Press Release: Lexeo Therapeutics Reports First Quarter 2025 Financial Results and Operational Highlights

Press Release: Tango Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights

Press Release: Kaspi.kz 1Q 2025 Financial Results

TaskUs (TASK) Gets a Hold from RBC Capital

Can Buying CRISPR Therapeutics and Holding It Forever Make You a Millionaire?

Bombie's user base surpasses 12 million, becoming the world's first Web3 game to achieve explosive overseas success.

Should You Buy This Beaten-Down Artificial Intelligence (AI) Stock on the Dip?

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4539/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":670.0666,"timestamp":1747067270046,"preClose":641.20984,"halted":0,"volume":210089798,"delay":0,"changeRate":0.045004,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":28.85675,"latestTime":"05-12 12:27:50 EDT","open":650.43024,"high":677.25977,"low":650.43024,"amount":7104493904.046946,"amplitude":0.041842,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1747080000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.915757,"peRate":-2031.784145,"turnoverRate":0.015455,"increases":132,"decrements":48,"flats":6,"marketCap":488966208683.25,"floatMarketCap":344728747465.875},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":677.25977,"amplitude":0.041842,"preClose":641.20984,"low":650.43024,"pbRate":"5.915757","latestPrice":670.15405,"volume":210051114,"delay":0,"open":650.43024,"prevYearClose":648.26935,"prevWeekClose":641.2098,"prevMonthClose":599.1775,"prevQuarterClose":570.2879,"fiveDayClose":618.9004,"twentyDayClose":549.3906,"sixtyDayClose":819.4626,"secType":"PLATE","market":"US","turnoverRate":0.015452,"peRate":-2031.784145,"marketCap":488955167533.25,"floatMarketCap":344719894035.875,"timestamp":1747067265938,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":132,"down":48,"flat":8},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2534203148","title":"Paul R. Vigano, 10% Owner, Reports Disposal of Common Shares in Aveanna Healthcare Holdings Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2534203148","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534203148?lang=en_us&edition=fundamental","pubTime":"2025-05-12 23:16","pubTimestamp":1747062965,"startTime":"0","endTime":"0","summary":"Paul R. Vigano, a 10% Owner, reported a disposal of common shares of Aveanna Healthcare Holdings Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aveanna Healthcare Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 12, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250512:nNDL3VhMFH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","AVAH","BK4539"],"gpt_icon":0},{"id":"2534527066","title":"J.H. Whitney Equity Partners VII, LLC Reports Disposal of Common Shares of Aveanna Healthcare Holdings Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2534527066","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534527066?lang=en_us&edition=fundamental","pubTime":"2025-05-12 22:52","pubTimestamp":1747061574,"startTime":"0","endTime":"0","summary":"J.H. Whitney Equity Partners VII, LLC, a beneficial owner, reported the disposal of common shares of Aveanna Healthcare Holdings Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aveanna Healthcare Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 12, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250512:nNDL3VN3qB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","AVAH","BK4196"],"gpt_icon":0},{"id":"2534770352","title":"Regencell Bioscience Holdings Ltd trading halted, volatility trading pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2534770352","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534770352?lang=en_us&edition=fundamental","pubTime":"2025-05-12 22:31","pubTimestamp":1747060301,"startTime":"0","endTime":"0","summary":"10:25 EDT Regencell Bioscience (RGC) Holdings Ltd trading halted, volatility trading pause Published first on TheFly – the ultimate source for real...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regencell-bioscience-holdings-ltd-trading-halted-volatility-trading-pause-26?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regencell-bioscience-holdings-ltd-trading-halted-volatility-trading-pause-26?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4539","RGC"],"gpt_icon":0},{"id":"2534710592","title":"EverCommerce Is Maintained at Equal-Weight by Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2534710592","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534710592?lang=en_us&edition=fundamental","pubTime":"2025-05-12 22:17","pubTimestamp":1747059420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/EVCM/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 12, 2025 10:17 ET (14:17 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","EVCM","BK4023"],"gpt_icon":0},{"id":"2534276130","title":"Gold Futures Slump as U.S., China Agree to Substantial Tariff Cuts -- Commodities Roundup","url":"https://stock-news.laohu8.com/highlight/detail?id=2534276130","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534276130?lang=en_us&edition=fundamental","pubTime":"2025-05-12 21:50","pubTimestamp":1747057800,"startTime":"0","endTime":"0","summary":"--European benchmark gas is up 3.7% at 35.90 euros a megawatt-hour. --Gold futures are down 2.9% at $3,246.10 a troy ounce. --LME three-month copper futures are up 0.7% at $9,503 a metric ton. Gold futures slid as the U.S. and China agreed to substantially lower tariffs, increasing risk-on sentiment in markets.Continuous gold futures on the New York Mercantile Exchange fell 3.75% to $3,218.70 a troy ounce in European morning trading. They had dipped as low as $3,216.00 a troy ounce earlier in the session--the lowest level since May 1. The precious metal remains up nearly 20% in the year to date on safe-haven demand, reflecting U.S. tariff-driven market volatility and geopolitical conflicts.NRG Energy to Acquire LS Power Portfolio in $12 Billion Deal. NRG Energy has agreed to acquire LS Power's portfolio of natural gas generation facilities and power plant platform in a cash-and-stock deal with an enterprise value of about $12 billion.The Canadian mining company, primarily focused on co","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237438978.USD","COB.AU","HBM","QMmain","LU0251131958.USD","LU0278409577.USD","DUG","LU0106831901.USD","TTE","BZmain","LU1868836591.USD","S32.AU","DDG","LU2129689605.HKD","LU0742534661.SGD","SCO","GLNCY","IE00B19Z3B42.SGD","LU0096364046.USD","LU2750360997.AUD","NGLOY","DWT","BK7095","LU2129689514.USD","LU2237443978.SGD","LU0061475181.USD","USO","LU1571399168.USD","BK4552","LU0320765646.SGD","LU0300736492.USD","LU1162221912.USD","UCO","BK4516","LU1668664300.SGD","SHEL","LU0098860793.USD","ADC","DOLE","CLmain","LU2236285917.USD","BK4127","BP","NRG","BK4539","IE00BSNM7G36.USD","BK7504","EQNR","IE0002270589.USD"],"gpt_icon":0},{"id":"2534745972","title":"Regencell Bioscience Shares Soar 24.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534745972","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534745972?lang=en_us&edition=fundamental","pubTime":"2025-05-12 21:47","pubTimestamp":1747057631,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250512:nFWN3RK0DS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4539","RGC"],"gpt_icon":0},{"id":"2534276914","title":"What to expect in the week ahead for the altcoin market: KAITO, STX and more                \n\n7 seconds ago","url":"https://stock-news.laohu8.com/highlight/detail?id=2534276914","media":"cryptonews","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534276914?lang=en_us&edition=fundamental","pubTime":"2025-05-12 21:45","pubTimestamp":1747057525,"startTime":"0","endTime":"0","summary":"In the next few days, the altcoin market is gearing up for a range of major events in the crypto space that could potentially influence price action and market sentiment. Here are just a few major token events to look out for in the week ahead.From token unlocks to project roadmaps, these altcoins are preparing to unveil a number of highly anticipated announcements that will keep traders on the edge of their seats and watching the charts closely.Here are a few altcoin announcements to keep an eye on in the following week:. A total of 65 million APT  tokens will be unlocked on May 12, according to DropsTab’s token unlock calendar. These tokens are part of the vesting schedule that features a 12-month cliff followed by monthly unlocks over 36 months, with the first six months releasing 11,875,000 APT each.BTC: VanEck’s onchain economy ETF launch on May 14. The momentum of VanEck’s ETF could further fuel Bitcoin ’s ongoing rally after it surpassed the $105k mark.On May 15, Stacks  will en","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://crypto.news/what-to-expect-in-the-week-ahead-for-the-altcoin-market-kaito-stx-and-more/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"crypto_news_highlight","symbols":["09042","BTC.USD.CC","BK4539","FDN","03008","BK4086","APT.AU","BK4170","BK4568","BK4594","BTC.USD.HKCC","IE00B894F039.SGD","BK4512","03439","BTC","APT.USD.CC","BK4601","03042","ETH.USD.CC","ETH.USD.HKCC","ETH","IE00B19Z9P08.USD","IE00B19Z9Z06.USD","83042","STX.AU","BTC.AU","APT.USD.HKCC","S","XBTmain","LU2286300806.USD","BK4561","BTCmain","BK4550","BK4560","BK1611","SHL.AU","09008","BK7142","BK7124","09439","BK4097","APT","BK4585","BK4588","STX"],"gpt_icon":1},{"id":"2534538272","title":"Eric Trump-backed American Bitcoin to go public through all-stock merger","url":"https://stock-news.laohu8.com/highlight/detail?id=2534538272","media":"Reuters","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534538272?lang=en_us&edition=fundamental","pubTime":"2025-05-12 21:43","pubTimestamp":1747057384,"startTime":"0","endTime":"0","summary":"UPDATE 1-Eric Trump-backed American Bitcoin to go public through all-stock mergerUpdates shares in paragraph 5By Ateev Bhandari","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250512:nL4N3RK18T:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UPXI","BK4595","BK4023","HUT","BK4539","BK4183","GRYP","BK4600"],"gpt_icon":0},{"id":"2534276043","title":"US Stock Crypto Concept Stocks Soar, Coinbase Up 4.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534276043","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534276043?lang=en_us&edition=fundamental","pubTime":"2025-05-12 21:33","pubTimestamp":1747056780,"startTime":"0","endTime":"0","summary":"BlockBeats News, May 12th: US stock cryptocurrency concept stocks saw a general rise, including:· Strategy rose by 0.34%;· Coinbase rose by 4.21%;· MARA Holdings rose by 4.12%;· Riot Platforms rose by 6.01%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//en/flash/293506","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_live","symbols":["BK4535","BK4516","LU1861558580.USD","BK4585","BK4023","BK4551","BK4596","BK4600","LU1861559042.SGD","BK4554","BK4547","BK4588","COIN","BK4539","BK4595","BK4112","STRK"],"gpt_icon":0},{"id":"2534278956","title":"Analysts’ Top Healthcare Picks: Tenaya Therapeutics (TNYA), Green Thumb Industries (GTBIF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2534278956","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534278956?lang=en_us&edition=fundamental","pubTime":"2025-05-12 21:00","pubTimestamp":1747054835,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Tenaya Therapeutics (TNYA – Research Report), Green ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-tenaya-therapeutics-tnya-green-thumb-industries-gtbif?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-tenaya-therapeutics-tnya-green-thumb-industries-gtbif?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4557","TNYA","GTBIF","BK4539","BK4139","HCSG","BK4007","BK4137"],"gpt_icon":0},{"id":"2534278980","title":"NeuroPace (NPCE) Gets a Buy from Lake Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2534278980","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534278980?lang=en_us&edition=fundamental","pubTime":"2025-05-12 20:58","pubTimestamp":1747054721,"startTime":"0","endTime":"0","summary":"Lake Street analyst Frank Takkinen reiterated a Buy rating on NeuroPace (NPCE – Research Report) today and set a price target of $20.00. The compan...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/neuropace-npce-gets-a-buy-from-lake-street-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/neuropace-npce-gets-a-buy-from-lake-street-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","NPCE","BK4539"],"gpt_icon":0},{"id":"2534152220","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2534152220","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534152220?lang=en_us&edition=fundamental","pubTime":"2025-05-12 20:46","pubTimestamp":1747053979,"startTime":"0","endTime":"0","summary":"Vivakor  shares were down 60% in recent Monday premarket activity, continuing Friday's loss.Nuvve  shares slipped 40%, erasing the previous session's 144% surge.Pan American Silver  stock fell 8%, a day after it said it agreed to acquire MAG Silver for about $2.1 billion in cash and stock.Metsera  stock was 5% lower after it posted a higher-than-expected Q1 net loss.Dole  shares slipped 2% after it reported lower Q1 adjusted earnings and revenue from a year earlier.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SILmain","PAAS","BK4139","BK4539","BK4144","BK4210","LU1223082196.USD","NVVE","VIVK","BK4096","BK4588","BK4212","DOLE","MTSR","LU1223083913.SGD","BK4585","BK4120"],"gpt_icon":1},{"id":"2534822143","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: InflaRx (IFRX), Treace Medical Concepts (TMCI) and Amarin (AMRN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2534822143","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534822143?lang=en_us&edition=fundamental","pubTime":"2025-05-12 19:32","pubTimestamp":1747049557,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on InflaRx (IFRX – Research Report), Treace Medical C...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-inflarx-ifrx-treace-medical-concepts-tmci-and-amarin-amrn?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-inflarx-ifrx-treace-medical-concepts-tmci-and-amarin-amrn?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","BK4082","HCSG","IFRX","BK4137","TMCI","AMRN"],"gpt_icon":0},{"id":"2534223741","title":"Press Release: Lexeo Therapeutics Reports First Quarter 2025 Financial Results and Operational Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2534223741","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534223741?lang=en_us&edition=fundamental","pubTime":"2025-05-12 19:00","pubTimestamp":1747047600,"startTime":"0","endTime":"0","summary":"Announced positive interim data for LX2006 from Phase 1/2 studies in Friederich ataxia  cardiomyopathy; frataxin expression and LVMI improvement exceeded co-primary target thresholds for planned registrational study. LX2006 registrational study expected to begin by early 2026; commencing enrollment in prospective natural history study, CLARITY-FA, in Q2 2025 to serve as concurrent external control. Phase 1/2 clinical trial of LX2020  currently enrolling patients in Cohort 3; interim clinical data update on track for second half of 2025. Redeployed $20 million to focus on clinical-stage programs; cash, cash equivalents and investments of $106.9 million expected to provide operational runway into 2027. \"Based on the highly encouraging clinical data shared to date, we believe LX2006 could be transformational and establish a new standard of care in FA cardiomyopathy,\" said R. Nolan Townsend, Chief Executive Officer of Lexeo Therapeutics. \"We look forward to beginning enrollment in the CLAR","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FA","BK4539","BK4130","BK4139","LXEO","BK4535"],"gpt_icon":0},{"id":"2534223673","title":"Press Release: Tango Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2534223673","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534223673?lang=en_us&edition=fundamental","pubTime":"2025-05-12 19:00","pubTimestamp":1747047600,"startTime":"0","endTime":"0","summary":"-- Data update from ongoing TNG462 Phase 1/2 monotherapy trial expected 2H 2025 --. -- Combination trial of TNG462 + Revolution Medicines RAS inhibitors on track for enrollment 2Q 2025 --. -- Cash position of $217 million as of March 31, 2025; cash runway extended into 1Q 2027 with reduction of preclinical spend --. BOSTON, May 12, 2025  -- Tango Therapeutics, Inc. , a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, reported its financial results for the first quarter ended March 31, 2025, and provided business highlights.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861215975.USD","ON","BK4539","LU1720051108.HKD","BK4585","LU0724618433.USD","IE00BZ199S13.USD","LU2357305700.SGD","LU1861220033.SGD","LU0124384867.USD","LU1548497426.USD","BK4139","BK4141","BK4512","LU0348723411.USD","LU1854103824.USD","LU1978683503.SGD","LU1854104046.USD","LU2298322129.HKD","BK4007","TNGX","LU1861214812.USD","LENZ","BK4605","LU1720051017.SGD","LU2360107325.USD","BK4588","LU1861219969.SGD","IE00BD6J9T35.USD"],"gpt_icon":0},{"id":"2534223116","title":"Press Release: Kaspi.kz 1Q 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2534223116","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534223116?lang=en_us&edition=fundamental","pubTime":"2025-05-12 19:00","pubTimestamp":1747047600,"startTime":"0","endTime":"0","summary":"ALMATY, Kazakhstan, May 12, 2025  -- Joint Stock Company Kaspi.kz   which operates the Kaspi.kz and Kaspi Pay Super Apps in Kazakhstan and owns 65.41% of Hepsiburada in Türkiye, today published its unaudited consolidated IFRS financial results for the quarter ended 31 March 2025 .-- Our results for the first quarter of the year were broadly as we expected. -- 1Q 2025 Revenue up 21% year-over-year , net income up 16% YoY.This and all references below exclude Türkiye unless otherwise. -- Customer engagement strong with Monthly Transactions per Active Consumer. -- In Payments, operational gearing once again resulted in profit growth. -- Payments TPV and transactions up 23% and 17% YoY, respectively.-- Payments revenue and net income up 16% and 21% YoY, respectively.-- Marketplace Platform revenue growth continued to significantly outpace. -- Revenue up 33% YoY versus 20% GMV growth, with revenue boosted by. the growth of Kaspi Delivery, Kaspi Advertising and Classifieds.-- Fintech revenue","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2348774022.SGD","LU1481012133.USD","LU1668664300.SGD","LU1861217088.USD","LU0047713382.USD","LU0390137627.USD","LU0048575426.USD","BK4166","LU2153592121.USD","LU0251143458.SGD","LU0303821028.USD","BK4539","LU0562313402.USD","LU0303823156.USD","LU1051768304.USD","LU0651946864.USD","LU1051769294.HKD","LU1046231319.USD","KSPI","LU2360107671.USD","LU0231793349.USD","LU0132412106.USD","HEPS","LU0651947912.USD","LU1861220207.SGD","LU1515016050.SGD","LU0261950470.USD","BK4122","LU0215049551.USD","BK4220","LU0390136736.USD","LU0106831901.USD","LU0196876865.USD","LU0390137544.SGD"],"gpt_icon":0},{"id":"2534225947","title":"TaskUs (TASK) Gets a Hold from RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2534225947","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534225947?lang=en_us&edition=fundamental","pubTime":"2025-05-12 18:56","pubTimestamp":1747047418,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Daniel Perlin maintained a Hold rating on TaskUs (TASK – Research Report) on May 9 and set a price target of $16.50. The compan...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/taskus-task-gets-a-hold-from-rbc-capital?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/taskus-task-gets-a-hold-from-rbc-capital?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4106","BK4535","BK4207","TASK","BK4539","BK4226"],"gpt_icon":0},{"id":"2534443862","title":"Can Buying CRISPR Therapeutics and Holding It Forever Make You a Millionaire?","url":"https://stock-news.laohu8.com/highlight/detail?id=2534443862","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534443862?lang=en_us&edition=fundamental","pubTime":"2025-05-12 18:18","pubTimestamp":1747045080,"startTime":"0","endTime":"0","summary":"The company has shown its revolutionary technology can deliver life-changing therapies. Now, it's about whether CRISPR Therapeutics can replicate the success across its promising pipeline.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/05/12/can-buying-crispr-therapeutics-and-holding-it-fore/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["IE00BJJMRZ35.SGD","BK4585","IE00BJT1NW94.SGD","BK4588","LU0757428866.USD","LU0889565916.HKD","SG9999001176.USD","LU1093756325.SGD","IE00B19Z9P08.USD","LU2362541273.HKD","BK4007","BK4532","LU1093756168.USD","VERX","IE00B19Z3B42.SGD","LU1559883803.SGD","LU2236285917.USD","SG9999001176.SGD","LU2417539215.USD","BK4611","BK4567","BK4023","IE0002141913.USD","LU0823416689.USD","LENZ","LU0256863811.USD","LU1069344957.HKD","VRTX","LU2362540622.SGD","LU2237438978.USD","LU1815336091.USD","CRSP","IE0002270589.USD","IE00B19Z9Z06.USD","LU0058720904.USD","LU1861559042.SGD","LU2324357040.USD","LU0234570918.USD","IE00B2B36J28.USD","LU0061475181.USD","LU0566484027.USD","LU1035775433.USD","LU0109394709.USD","IE00BFTCPJ56.SGD","LU1585245621.USD","BK4539","BK4139","IE00B4R5TH58.HKD","IE00BZ9MQY76.HKD","LU2456880835.USD"],"gpt_icon":0},{"id":"2534246342","title":"Bombie's user base surpasses 12 million, becoming the world's first Web3 game to achieve explosive overseas success.","url":"https://stock-news.laohu8.com/highlight/detail?id=2534246342","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534246342?lang=en_us&edition=fundamental","pubTime":"2025-05-12 17:33","pubTimestamp":1747042380,"startTime":"0","endTime":"0","summary":"BlockBeats News, May 12th, the total number of users of the Web3 casual game Bombie has exceeded 12 million, covering the Telegram and LINE ecosystems, becoming the world's first Web3 casual game project to achieve explosive growth overseas. Bombie, evolved from the popular WeChat game \"The Great Journey\" gameplay, inherits its \"lightweight, closed-loop, high stickiness\" design logic, and is now fully transitioning to a Web3 model.Bombie COO Barry stated in an interview that as the TGE approaches, the platform's native token $BOMB continues to gain popularity. At the same time, the new ecosystem game CapyBomb has officially launched, enabling players to stake $BOMB with a low threshold through the IAS in-app staking mechanism, continuously receiving rare props, additional rewards, and eligibility for airdrops. CapyBomb combines long-term sustainable gameplay with rewards and fun, distinguishing itself from the short-term high-yield model of traditional GameFi.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//en/flash/293453","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_live","symbols":["LU2272731600.USD","US12M.BOND","BK4198","US2Y.BOND","US3Y.BOND","BK4009","LU2272731782.SGD","LU2211815571.USD","LU1992135472.HKD","COO","BK4588","US5Y.BOND","BK4224","BK4585","US30Y.BOND","LINE","US10Y.BOND","US6M.BOND","GB00BDT5M118.USD","US7Y.BOND","BK4539","LU1992135399.USD","IAS"],"gpt_icon":0},{"id":"2534462216","title":"Should You Buy This Beaten-Down Artificial Intelligence (AI) Stock on the Dip?","url":"https://stock-news.laohu8.com/highlight/detail?id=2534462216","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534462216?lang=en_us&edition=fundamental","pubTime":"2025-05-12 16:18","pubTimestamp":1747037880,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals has an innovative, AI-focused approach to developing drugs.However, the company has yet to find tangible success and faces several headwinds.Artificial intelligence  has taken over Wall Street. The leaders in this rapidly growing field are attracting significant attention. Many have produced outstanding returns over the past two years. Naturally, most investors want to cash in on this, but the biggest names in the industry tend to trade at steep premiums. It might be worth considering smaller, under-the-radar AI-focused companies that haven't performed well yet but boast significant upside potential.And some think that description fits Recursion Pharmaceuticals , an AI-focused biotech company. The stock has attracted the attention of some of the most famous names in the investing world, including Cathie Wood, CEO of Ark Invest. But is Recursion Pharmaceuticals really worth investing in right now after shedding 35% of its value this year?Second, recent politica","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/05/12/should-you-buy-this-beaten-down-artificial-intelli/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["BK4548","BK4609","BK4588","BK4023","AI","RXRX","OS","BK4551","BK4585","BK4587","BK4539","BK4611","BK4543","BK4528","BK4139","BK4097"],"gpt_icon":1}],"pageSize":20,"totalPage":49,"pageCount":1,"totalSize":968,"code":"91000000","status":"200"}]}}